First approved in 1983, Zantac, also known as ranitidine, was pulled from the U.S. market in 2020 after the FDA was notified that the drug led ... GSK wins latest Zantac lawsuit in Illinois. 1w. ...

The In re Zantac (Ranitidine) Litigation appeal provides the First State's high court a prime opportunity to clarify Delaware law on those two issues and remind trial judges that in most instances ...

GSK topped the Stoxx Europe 600 index after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac ...

GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.

The lawsuit aims to seek damages for the investors who felt the company was not being honest about the drug’s potential cancer risk that they had known about prior, the Ohio AG’s office said.

Zantac went on sale in the UK in 1981. ... British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed.